DuPuy Reaches $2.5 Bln Deal To Compensate Revision Patients 2013
Read Complete Article Here
November 19, 2013
Health care giant Johnson & Johnson Co.’s ( JNJ ) medical-device unit DePuy
Orthopaedics, Inc., announced Tuesday that it has reached a $2.5 billion
settlement to compensate patients in the U.S. who were subject to a second
surgery, known as revision surgery, to replace their recalled DePuy ASR Hip
system.
More than 12,000 thousand lawsuits were filed by patients against DePuy in
federal and state courts related to… Read the rest